IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.344
EU - Europa 1.457
AS - Asia 326
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
OC - Oceania 5
Totale 11.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.337
IT - Italia 314
SE - Svezia 296
UA - Ucraina 254
FI - Finlandia 192
CN - Cina 182
GB - Regno Unito 177
DE - Germania 84
VN - Vietnam 77
BG - Bulgaria 57
JO - Giordania 26
LU - Lussemburgo 22
AT - Austria 17
TR - Turchia 15
IN - India 9
RU - Federazione Russa 9
CA - Canada 7
JP - Giappone 5
NL - Olanda 5
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CL - Cile 4
ES - Italia 4
IR - Iran 4
PL - Polonia 4
AU - Australia 3
EU - Europa 3
FR - Francia 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
IL - Israele 2
KR - Corea 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HR - Croazia 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
PT - Portogallo 1
RS - Serbia 1
Totale 11.146
Salva come PNG Salva come JPEG
Città #
Fairfield 1.706
Chandler 944
Woodbridge 786
Ashburn 690
Seattle 687
Houston 620
Jacksonville 605
Cambridge 581
Wilmington 554
San Mateo 333
Ann Arbor 322
Princeton 224
Beijing 117
Trento 115
San Diego 108
Helsinki 86
London 81
Dearborn 79
Lawrence 70
Boardman 67
Sofia 57
Como 56
Dong Ket 50
Falls Church 40
Bremen 34
Norwalk 27
San Paolo di Civitate 27
Tolentino 23
Hesperange 22
Des Moines 21
Altamura 20
Bend 20
Washington 17
Chiswick 15
Düsseldorf 15
Izmir 15
Andover 13
Hefei 11
Kunming 10
Vienna 10
Phoenix 9
Nanjing 8
New Bedfont 8
Riva Del Garda 8
Toronto 7
Chicago 6
Civitanova Marche 6
Bolzano 5
Dormagen 5
Tappahannock 5
Guangzhou 4
Laurel 4
Mountain View 4
Redmond 4
Bovolone 3
Fuzhou 3
Hebei 3
San Michele All'adige 3
Tokai 3
Turin 3
Zhengzhou 3
Anaheim 2
Asolo 2
Atlanta 2
Auckland 2
Augusta 2
Brisbane 2
Bristol 2
Brunico 2
Castello Molina di Fiemme 2
Chapel Hill 2
Clearwater 2
Costa Mesa 2
Dallas 2
Falkenstein 2
Fremont 2
Hangzhou 2
Islington 2
Lagundo 2
Milan 2
Nanchang 2
Nuremberg 2
Oslo 2
Raleigh 2
Redwood City 2
Romainville 2
Sabz 2
San Francisco 2
Vicenza 2
Albissola Marina 1
Alleghe 1
Amsterdam 1
Arsiè 1
Berlin 1
Bolsena 1
Brentford 1
Brussels 1
Caivano 1
Canberra 1
Changsha 1
Totale 9.449
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 241
Inherited determinants of early recurrent somatic mutations in prostate cancer 233
EthSEQ: ethnicity annotation from whole exome sequencing data 185
A highly specific SpCas9 variant is identified by in vivo screening in yeast 158
ASEQ: Fast allele-specific studies from next-generation sequencing data 139
Personalized in vitro and in vivo cancer models to guide precision medicine 139
Patient derived organoids to model rare prostate cancer phenotypes 138
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 135
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 133
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 124
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 119
Genomic correlates of clinical outcome in advanced prostate cancer 117
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 116
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 112
TPES: Tumor Purity Estimation from SNVs 110
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 106
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 104
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 104
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 103
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 102
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 101
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 100
Ancestry-specific predisposing germline variants in cancer 98
The Molecular Taxonomy of Primary Prostate Cancer 97
Variants at IRX4 as prostate cancer expression quantitative trait loci. 96
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 96
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 96
Punctuated evolution of prostate cancer genomes. 95
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 95
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 95
In-silico identification and functional validation of allele-dependent AR enhancers 94
Testing mutual exclusivity of ETS rearranged prostate cancer. 92
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 91
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 90
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 89
Oncogene-mediated alterations in chromatin conformation 89
Role of non-coding sequence variants in cancer 89
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 88
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 88
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 88
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 88
Clonal evolution of chemotherapy-resistant urothelial carcinoma 88
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 88
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 86
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 86
Tumor clone dynamics in lethal prostate cancer 86
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 86
A step toward functionally characterized prostate cancer molecular subtypes. 85
The virtual case: a new method to completely digitize cytological and histological slides. 85
The genomic complexity of primary human prostate cancer. 85
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 85
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 85
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 84
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 84
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 83
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 83
Large oncosomes mediate intercellular transfer of functional microRNA. 82
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 82
Integrative clinical genomics of advanced prostate cancer 82
Plasma AR and abiraterone-resistant prostate cancer 82
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 82
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 81
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 80
TMABoost: an integrated system for comprehensive management of tissue microarray data. 80
Digital Pathology: Science Fiction? 80
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 80
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. 80
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 79
Design and initial implementation of a regional tele-oncology project. 78
The landscape of somatic copy-number alteration across human cancers. 78
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 78
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 78
Molecular genetics of prostate cancer: Emerging appreciation of genetic complexity 77
ERG rearrangement metastasis patterns in locally advanced prostate cancer. 76
EML4-ALK fusion lung cancer: a rare acquired event. 76
Unraveling the clonal hierarchy of somatic genomic aberrations 76
Genetic predisposition to prostate cancer: Update and future perspectives 76
The lethal clone in prostate cancer: redefining the index 76
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 76
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes. 75
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 75
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 75
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 74
Antibody-based detection of ERG rearrangement-positive prostate cancer. 74
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 74
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 74
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation 74
A computational framework discovers new copy number variants with functional importance. 74
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. 74
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines. 74
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. 73
Recurrent gene fusions in prostate cancer 73
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. 72
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. 72
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 72
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 72
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. 72
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. 71
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 71
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target 71
Totale 9.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 292
selected - selezionate 0
volume - volumi 131
Totale 38.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.100 0 0 0 2 0 140 4 0 0 174 417 363
2019/20202.874 164 129 209 303 313 201 337 277 429 246 107 159
2020/20212.580 40 355 159 328 264 180 151 162 160 229 281 271
2021/20222.147 249 327 14 92 35 81 83 388 136 212 178 352
2022/20232.024 264 232 13 324 209 312 35 146 256 35 124 74
2023/2024215 49 87 79 0 0 0 0 0 0 0 0 0
Totale 11.412